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Common variants in the genes of
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the Pakistani subjects
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Abstract
Background: Serum Triglyceride (TG) and High Density Lipoprotein (HDL-C) levels are modifiable coronary artery
disease (CAD) risk factors. Polymorphisms in the genes regulating TG and HDL-C levels contribute to the development
of CAD. The objective of the current study was to investigate the effect of four such single nucleotide polymorphism
(SNPs) in the genes for Lipoprotein Lipase (LPL) (rs328, rs1801177), Apolipoprotein A5 (APOA5) (rs66279) and
Cholesteryl ester transfer protein (CETP) (rs708272) on HDL-C and TG levels and to examine the association of
these SNPs with CAD risk.
Methods: A total of 640 subjects (415 cases, 225 controls) were enrolled in the study. The SNPs were genotyped by
KASPar allelic discrimination technique. Serum HDL-C and TG were determined by spectrophotometric methods.
Results: The population under study was in Hardy Weinberg equilibrium and minor allele of SNP rs1801177 was
completely absent in the studied subjects. The SNPs were association with TG and HDL-C levels was checked through
regression analysis. For rs328, the effect size of each risk allele on TG and HDL-C (mmol/l) was 0.16(0.08) and −0.11(0.05)
respectively. Similarly, the effect size of rs662799 for TG and HDL-C was 0.12(0.06) and −0.13(0.0.3) and that of rs708272
was 0.08(0.04) and 0.1(0.03) respectively. The risk allele frequencies of the SNPs were higher in cases than controls, but
the difference was not significant (p > 0.05) and SNPs were not associated with CAD risk (p > 0.05). The combined gene
score of four SNPs significantly raised TG and lowered HDL-C but did not increase CAD risk.
Conclusion: The studied SNPs were associated with TG and HDL-C levels, but not with CAD in Pakistani population
under study.
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Background
Lipoprotein lipase (LPL), a 61 kDa heparin releasable
enzyme is attached to capillary endothelium at glycos-
aminoglycan residues [1–3]. It is a rate limiting enzyme
in hydrolysis of triglycerides (TG) from core of chylomi-
crons (CM) and very low density lipoproteins (VLDL) into
free fatty acids and glycerol generating CM remnants from
CM, intermediate density lipoprotein (IDL) from VLDL
and eventually low density lipoprotein (LDL) cholesterol
by the action of hepatic lipase. Phospholipids and surface
free cholesterol are converted to HDL-C [4]. Decreased
LPL activity is associated with increased TG and de-
creased HDL-C levels and accumulation of atherogenic
TG rich lipoproteins in circulation [5–8]. Although
affected by environmental factors and life style, genetic
variants within a population may also influence TG and
HDL-C levels. It has been estimated that heritability
accounts for >30% hypertriglyceridemia cases [9].
The LPL gene is highly polymorphic and more than
100 variants have been identified in it [10]. The common
variants with modest effect on TG and HDL-C levels
may prove to be an important CAD risk contributors at
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population levels. The polymorphism LPL rs328 is a C > G
change in exon nine and changes the codon for serine 447
(TCA) to TGA which is a stop codon hence also given the
name Ser447Stop or S447X. This results in pre-mature
truncation of the protein which is short of two amino
acids. The product of LPLS447X is missing C terminal
serine and glycine residues and also generates restriction
site for the enzyme MnlI [11]. LPL rs1801177 is a mis-
sense polymorphism and causes substitution of aspartic
acid (D) to asparagine (N) hence also denoted as Asp9Asn
or D9N.
Apo-lipoprotein A5 (ApoA5) is part of VLDL, HDL
and CM and is a major regulator of blood TG and HDL-
C through interaction with LDLR [12]. ApoA5 controls
TG levels directly by increasing the breakdown of TG
rich lipoproteins through the action of LPL and indir-
ectly by reducing VLDL biosynthesis [13]. The expres-
sion of ApoA5 is in inverse relation with circulating
plasma TG levels. ApoA5 knockout mice had 4 folds
higher TG concentration and when knocked in with
human ApoA5, it caused a 50-70% reduction in mouse
serum TG level [14]. The APOA5 rs662799 is the most
studied SNP in the promoter region of this gene [15].
Different allele frequencies of this polymorphism have
been reported in Chinese and Europeans [16] and is the
most effective SNP in ApoA5 gene [17]. The SNP is as-
sociated with decreased ApoA5 levels and high plasma
TG levels and the association has been shown to be in-
dependent of other factors.
Cholesteryl ester transfer protein (CETP) transfers
lipids between lipoproteins and redistributes triglycerides,
cholesteryl esters and phospholipids between lipoproteins
[18, 19]. An inverse correlation exists between CETP
activity and blood HDL-C levels [20]. Many functional
polymorphisms have been identified in CETP gene [21].
The association of CETP with HDL-C is stronger than any
other locus in the genome [22]. The polymorphism CETP
rs708272 also known as Taq1B polymorphism in this gene
is the most studied one. The effect of this SNP is also
modulated by the factors like smoking and alcohol
consumption [21].
The effect of these common variants in the genes for
lipid metabolism on blood lipid levels has been studied
well in Caucasians. However, the data on Pakistani
people is limited. As is known that the allele frequencies
and linkage disequilibrium of a SNP with tag/functional
SNP may vary among ethnicities, the authors of the
study hypothesized that the SNPs in the above men-
tioned genes may have strong effect on blood TG and
HDL-C levels in Pakistani population which is facing
high CAD burden. In this study, we examined the effect
of polymorphisms LPL rs328, LPL rs1801177, ApoA5
rs662799 and CETP rs708272 on serum TG and HDL-C
levels and their association with CAD. For this purpose,
a case control study was opted. As the common variants
individually have modest effects, the cumulative effect of
the four SNPs was examined by combining them in a
small gene score.
Methods
Study subjects
A total of 640 subjects including 415 CAD cases and
225 healthy controls were enrolled in the study. The in-
clusion criteria for selection of cases and controls has
been already described [23]. The CAD patients were se-
lected from tertiary care hospitals of the province of
Punjab, Pakistan. These were diagnosed cases based
upon the ECG, cardiac echo, radiologic and troponine
T/I levels. These cases were recently diagnosed of having
CAD and were not taking any lipid lowering or antihy-
pertensive drug. Control subjects were apparently
healthy individuals from the general population with
BMI 18.5-22.99 Kg/m2 and no history of heart disease.
The exclusion criteria included the presence of any
chronic ailment like chronic liver or kidney disease, can-
cers or any ongoing acute infection or disease and CAD
patients with obesity. The participants gave a written
informed consent and the study was approved by the
institutional ethical committee, university of the Punjab,
Lahore.
Biochemical and genetic analysis
Serum TG and HDL-C were measured using commer-
cially available kits (Human diagnostics, Germany). A 96
well plate reader, Epoch (Biotek instruments, Highland
Park) was used for end stage spectrophotometric mea-
surements. The DNA was extracted from whole blood
leucocytes using commercially available genomic DNA
purification kit (Promega Wizard, USA). The DNA was
quantified using nano drop (ND-8000, USA). The DNA
samples were arrayed into 384 well plates (Micro Amp)
by an automated robotic liquid handling system (Biomerk
FX, Beckman Coulter). The SNPs were genotyped by
florescence based allelic discrimination technique KASPar,
the details described elsewhere [24]. After amplification,
the results were analysed on ABI Prism 7900HT (Applied
Biosystems/Life Technologies) and the genotypes were
called by sequence detection software (SDS, version 2.0).
The sequence of primers and probes used for KASPar are
given in Additional file 1: Table S1. The genotyping results
were also confirmed by direct DNA sequencing (Source
Biosciences, UK) and the results were always same. The
DNA fragment containing polymorphism was amplified
using commercially available master mix (Qiagen). The
sequence of primers used for direct DNA sequencing is
given in Additional file 2: Table S2. The genotyping quality
was also checked by the inclusion of non-template con-
trols and known heterozygotes in the test plate.
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Statistical analysis
The results were analysed using statistical package for
social sciences (SPSS), IBM version 22.0. Independent
sample t test was used to compare continuous variables
between cases and controls. Hardy-Weinberg equilib-
rium of genotypes in studied subjects was assessed by a
chi squared test. The allele frequencies were compared
between cases and controls by chi squared test [25]. The
association of SNPs with TG and HDL-C was estimated
by linear regression. As CAD is a binary variable, the as-
sociation of SNPs with CAD was calculated by binary lo-
gistic regression. One way analysis of variance (ANOVA)
was used to calculate mean TG and HDL-C levels along
different genotypes. The effect size (β effect) which is
per risk allele increase/decrease in TG and HDL-C levels
was calculated by linear regression and indicated by β
with standard error (Se). Differences in regression slope
between groups were tested by fitting an interaction
term in the regression model. The relationship between
gene score, frequency of individuals with a particular
gene score and TG and HDL-C was plotted using an
excel spread sheet. For all measurements, statistically
significant cut-off was adjusted at a p-value <0.05. An
un-weighted gene score of four SNPs was calculated by
summing up the number of risk alleles at all the four loci.
Results
The baseline biochemical and anthropometric parame-
ters of the subjects under study are given in Table 1.
Serum TG and HDL-C were significantly higher in the
cases than the controls. The CAD cases were more
hypertensive, diabetic, and smoking rate was also signifi-
cantly higher than controls. The genotyping rate for all
the SNPs was >95%. The basic features of the study
SNPs and the Hardy Weinberg equilibrium p-values are
provided in the Additional file 3: Table S3. The study
population was in Hardy Weinberg equilibrium collect-
ively as well as individually among cases and controls
except LPL rs1801177, for which a quite monomorphic
picture was observed and risk allele was absent in the
subjects studied. In the case of rs328, rs662799 and
rs708272, the RAFs were higher in the cases than the
controls, but the difference was not statistically signifi-
cant as the chi squared p values were >0.05. A mean
gene score of four SNPs was also not significantly higher
in the cases than the controls (Table 2). The SNPs under
study were not associated with CAD outcome. The odds
ratio (OR) of all the SNPs was higher in the cases than
the controls, but was not statistically significant. The
combined gene score of 4 SNPs was also not associated
with CAD (Table 3).
Association of the selected SNPs with serum triglyceride
and high density lipoprotein cholesterol levels
The effect of SNPs on TG and HDL-C levels was exam-
ined individually. The risk alleles of all the SNPs raised
TG levels, but the β effect was only marginally signifi-
cant. The risk alleles significantly lowered HDL-C levels
in the subjects under study as shown by their β effect
p values <0.05 (Table 4). Individually, each risk allele
increased TG and decreased HDL-C and the com-
bined gene score was significantly associated with
both TG and HDL-C levels (Table 5).
Quantitative effect of SNPs on the serum parameters
The mean increase in TG and a decrease in HDL-C with
the increasing number of risk alleles and the difference
in TG and HDL-C levels between those having lowest
and highest number of risk alleles was measured. It was
evident that TG was significantly higher and HDL-C was
significantly lower in subjects having highest number of
risk allele than those having lowest number of risk alleles
(Table 6). The correlation between TG/HDL-C, gene
score and CAD was also examined. It was clear that
more CAD cases showed skewed distribution towards
the high gene score and TG levels. Whereas, more
Table 1 Anthropometric and biochemical features of the subjects
under study
Variables Cases Controls p-value
Sample number 415 225 -
Age (years) 59.1 ± 12.6 56 ± 10.5 0.002
Gender
Males (n) 222 123 0.27
Females (n) 193 102
Diabetes (%) 64.6 13.6 5.1 × 10−34
Hypertension (%) 62.1 16.4 8.9 × 10−28
Smoking (%) 29.5 10.5 7.3 × 10−08
Total cholesterole (mmol/L) 5.37 4.54 7.8 × 10−13
Triglycerides (mmol/L) 2.4 2.12 2.3 × 10-5
HDL-C (mmol/L) 1.17 1.74 1.5 × 10−65
LDL-C (mmol/L) 2.74 2.19 6.1 × 10−21
Table 2 Comparison of RAFs between cases and controls
SNP Alleles RAF **p-value
Cases Controls
rs328 *C/G 0.94
(0.92-0.95)
0.91
(0.88-0.93)
0.060
rs1801177 G/A* 0 0 -
rs662799 A/G* 0.170
(0.14-0.20)
0.167
(0.13-0.20)
0.89
rs708272 *C/T 0.551
(0.52-0.59)
0.543
(0.50-0.59)
0.80
Mean gene
score ± SD
3.31 ± 0.94 3.23 ± 0.96 0.319
*is risk allele, **Chi squared p-value
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controls were shifted towards the left side of the normal
distribution curve with lower gene score and TG levels.
Contrarily to TG levels, as low HDL-C is a CAD risk
factor, a reverse pattern was observed. The control sub-
jects having higher HDL-C were concentrated towards
the left side, whereas more cases were located towards
the right side of the graph where the gene score was
high (Figs. 1 and 2).
Discussion
The prevalence of coronary artery disease has increased
globally, however, the larger proportion of the burden is
shared by the developing countries due to larger popula-
tions. As a complex disorder, it is difficult to dissect the
genetic and environmental components involved in the
progression of the disease. The unique social and cul-
tural practices prevailing in the Pakistani population
tend to concentrate the risk alleles predisposing to the
heart diseases. A large number of genes have been iden-
tified to be associated with the risk of cardiac diseases,
however, among these the genes involved in the synthe-
sis and metabolism of serum lipids have been subject of
intense research due to their clinical significance and
their ability to be quantified from the serum. We there-
fore selected variants in the genes that affect two key
serum lipids namely triglycerides and high density lipo-
protein cholesterol with the aim to check whether any
change in the genes results in the change of the serum
levels of these lipids.
The association of LPL polymorphisms with lipid
levels has been controversial [6]. Most of the SNPs
studied in this gene are rare and limited either to
single families or are restricted to isolated geographic
regions, whereas, common variants show differences
in allele frequencies among different populations [26].
In our study, minor allele (G) of the SNP LPL rs328
was found to be protective as its presence lowers TG
and raises HDL-C. The common allele (C) was the
risk allele. The carriers of risk allele had higher
plasma TG and lower HDL-C levels. However, a signifi-
cant difference in allele frequencies was not observed in
cases than controls. Since the LPL rs328 causes a protein
change towards the C terminal, hence it affects the legend
function of the protein leading to enhanced uptake
of lipoproteins at cellular receptors [27]. Hence this
is a gain in function change and such changes are
rare in nature and prevent from cardiovascular
events [28]. Such mutations are blessing in present
eras where people are living with a large number of
CAD risk factors. Our results were also inconsistent
with many other studies [29–33]. The risk allele of
Table 3 Association of the SNPs and gene score with CAD
SNP OR C.I p-value
rs662799 1.02 0.75–1.4 0.9
rs708272 1.03 0.82–1.3 0.81
rs328 1.5 0.98–2.3 0.06
rs1801177 – – –
Gene score 1.09 0.92–1.3 0.32
OR Odds ratio, C.I. Confidence interval
Table 4 Mean TG and HDL-C levels according to genotypes
SNP Genotype TG(mmol/L) HDL-C(mmol/L)
Mean TG 95% C.I Mean HDL-C 95% C.I
rs328 GG 1.93 ± 0.14 1.7–2.1 1.8 ± 0.17 1.5–2
GC 2.2 ± 0.71 2–2.3 1.44 ± 0.47 1.3–1.5
CC 2.3 ± 0.8 2.3–2.4 1.36 ± 0.44 1.3–1.4
β (se) 0.16(0.08) −0.11(0.05)
R2 0.2% 1.1%
p-value 0.06 0.02
rs662799 AA 2.27 ± 0.77 2.2–2.3 1.42 ± 0.45 1.4–1.5
AG 2.36 ± 0.83 2.2–2.5 1.28 ± 0.42 1.2–1.3
GG 2.56 ± 0.61 2.3–2.9 1.2 ± 0.41 1–1.4
β (se) 0.12(0.06) −0.13(0.03)
R2 0.6% 0.8%
p-value 0.053 <0.0001 0.001
rs708272 TT 2.22 ± 0.7 2.1–2.3 1.5 ± 0.42 1.4–1.6
CT 2.3 ± 0.8 2.2–2.4 1.4 ± 0.5 1.3–1.4
CC 2.4 ± 0.8 2.3–2.5 1.3 ± 0.42– 1.2–1.3
β (se) 0.08(0.04) 0.1(0.03)
R2 0.1% 1.9%
p-value 0.08 <0.001
β (Se) is per risk allele increase/decrease in lipid trait (Standard error)
Table 5 Correlation of gene score with TG and HDL-C
Gene score Correlation TG HDL-C
Unweighted Correlation r = 0.127 r = −0.246
β (se) 0.127 −0.246
p-value 0.001 <0.0001
Table 6 The effect of increasing risk allele on TG and HDL-C
Gene score TG HDL-C
(Δ) (Δ)
2 0.24 −0.44
3 0.05 −0.1
4 0.2 −0.08
5 0.06 −0.13
6 0.25 −0.41
aΔ 0.69 −1.16
Δ is change in TG and HDL-C levels with the addition of each risk allele in
gene score and aΔ is the difference in TG and HDL-C between those having
maximum and those having minimum number of risk alleles
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LPL rs1801177 was completely absent in the subjects
under study. In European people, the frequency of
this allele has been reported to vary from 1.6 – 6.7%
[34]. In another meta-analysis of 89 studies, the aver-
age frequency of risk allele was less than 3% ranging
from <0.1 – 8% [10]. We previously have reported
the RAF of 0.01% in another study group from
Pakistan [35].
We have replicated the effect of ApoA5 rs662799 in
Pakistani subjects and similar results were reported
in a study conducted in India where the RAF was as-
sociated with 19% increase in serum TG levels [36].
Similar TG raising effect of this SNP has also been
reported in Chinese people [15, 17]. Since the allele
frequencies of this SNP show interethnic variations
[37], its association with biochemical markers may
also vary in different ethnicities. Due to the presence
of protective variants, black population whether from
Caribbean or South African ancestries have low TG,
high HDL-C with less CAD mortality than the white
populations. Whereas South Asian immigrants to
Europe exhibit high mortality rate associated with
CAD secondary to raised serum TG and HDL-C [38].
Similar effect of this variant on blood lipids have
been documented in Caucasians, African American
and Hispanics [16, 39–41].
The presence of C allele of CETP rs708272 decreased
HDL-C and increased TG levels, both are CAD risk
factors. The results were in agreement with another
prospective study where each C allele was associated
with 3.1 mg/dl decrease in HDL-C concentration and
a 24% increase in CAD risk [42]. In a meta-analysis
of 98 published studies, the protective allele T was
associated with lower CETP mass and activity and
higher mean HDL-C levels [43]. Similar results have
also been reported in Chinese people [44]. The role
of CETP protein in lipid metabolism, though largely
studied, is still controversial. According to Thompson
et al. (2008), the CETP polymorphisms were associ-
ated with moderate inhibition of CETP activity, in-
creased HDL-C concentration and decreasing CAD
risk. However, some other studies have reported
greater CAD risk associated with decreased CETP
concentration [45, 46]. Furthermore, the effect of this
SNP is also modulated by environmental effects [21]
and the LD pattern of the tag SNPs in CETP gene is
also different in Asians compared to Europeans [20].
The study had some limitations, it included only four
polymorphisms in the lipid metabolism genes, inclusion
of other polymorphisms in a large number of genes af-
fecting serum lipid traits may have improved the results
of the study and should be considered in future. Further-
more, the study had relatively small sample size there-
fore future studies with even larger sample size and
more variants included, should be done in order to con-
firm the findings of the current study. The implications
of the study include providing the baseline information
about the polymorphisms in the Pakistani population
and the probable mechanism through which these vari-
ants may affect TG and HDL-metabolism.
Conclusion
In conclusion, the SNPs were associated with blood TG
and HDL-C levels additively but we could not find a sig-
nificant high risk allele frequency in the cases than the
controls. However, because the SNPs had small effect
size and association with CAD was also modest, we tried
to examine their combined effect on CAD risk and TG
and HDL-C levels. The association with CAD still
remained robust; however, the combined effect of the
SNPs was highly significant on TG and HDL-C levels.
This information can be used to establish panels com-
prising of common variants with modest effect on the
serum lipid traits to establish protocols for identifying
the genetic component responsible for changes in serum
lipid chemistry in a routine clinical setting.
Fig. 1 Green bars represent cases and grey bars represent controls
Fig. 2 Green bars represent cases and grey bars represent controls
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